Clinical Trials Directory

Trials / Completed

CompletedNCT03383315

Role of Prophylactic Metoclopramide With Tramadol in Trauma Patients

Role of Prophylactic Metoclopramide With Tramadol in Trauma Patients: A Randomised, Double Blind Placebo Controlled Trial

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
191 (actual)
Sponsor
University of Malaya · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Tramadol is widely used as analgesic in trauma patients. However, it causes side effects, most notably nausea and vomiting. This study aim to determine the role of prophylactic metoclopramide in preventing tramadol induced nausea and vomiting.

Conditions

Interventions

TypeNameDescription
DRUGTramadolOne dose of intravenous tramadol 50mg
DRUGMetoclopramideOne dose of intravenous metoclopramide 10mg
DRUGPlaceboSodium chloride 0.9%

Timeline

Start date
2017-07-01
Primary completion
2017-09-30
Completion
2017-09-30
First posted
2017-12-26
Last updated
2017-12-26

Locations

1 site across 1 country: Malaysia

Source: ClinicalTrials.gov record NCT03383315. Inclusion in this directory is not an endorsement.